Response to COVID-19 Vaccines in People with Chronic Conditions

Trial Objective

Response to COVID-19 Vaccines in People with Chronic ConditionsResearchers at National Jewish Health are working to understand the antibody response to COVID-19 vaccines in people with chronic diseases. Researchers are focused on the short-term and long-term antibody response by people with chronic respiratory diseases, as well as other chronic diseases.

Enrollment

Active Clinical Trials Currently Recruiting

Who Can Participate

Individuals 18 and older who have received or will be receiving the COVID-19 vaccine.

Age: 18+    Gender: Any Gender


Estimated Time Commitment

Up to 4 visits over about 1 year



Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Chanya Elkins
303.270.2161

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

Investigator Funded


Request More Information

By completing this form, you agree to learn more about this study and see if you qualify.


*
*
*
*
 I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: